Terguride, Partial D2 agonist

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The 5-HT2A receptor and dopamine D2 receptor are important in neurotransmission. The 5-HT2A receptor also termed serotonin receptor 2A is part of the G protein-coupled receptor family which is approximately 70 kDa in mass. It is predominantly expressed in the central nervous system especially in the cortex basal ganglia and limbic regions. The dopamine D2 receptor also widely distributed in the brain is important for modulating neurotransmitter release and synaptic plasticity. Like 5-HT2A the D2 receptor is also a G protein-coupled receptor and interacts significantly with dopamine neurotransmission.

Biological function summary

Neurotransmitter receptors like 5-HT2A and dopamine D2 are integral in signal transduction. These receptors do not function in isolation but form part of larger receptor complexes that influence many physiological processes. The 5-HT2A receptor modulates cognitive functions mood and hallucinations via serotonin signaling. The dopamine D2 receptor influences motor control and reward-related behavior. These receptors also display agonistic and antagonistic interactions— a partial D2 agonist or partial antagonist can modulate signaling pathways by fine-tuning receptor activity.

Pathways

Neurotransmitter receptors play roles in signal modulation pathways specifically the serotonin and dopamine systems. The 5-HT2A receptor participates in the phosphatidylinositol signaling pathway and interacts with proteins like PLC and PKC to modulate calcium release and neurite development. Meanwhile the dopamine D2 receptor is integral to the dopaminergic synapse pathway associating with adenylate cyclase and inhibiting cyclic AMP production. Both receptors converge in interacting with proteins that influence synapses and neurotransmitter release dynamics impacting numerous neural processes.

Alterations in 5-HT2A and dopamine D2 receptor function link to several neuropsychiatric conditions. Schizophrenia for example involves dysregulation of dopamine D2 receptor-linked signaling impacting brain regions associated with cognitive and emotional processing. Additionally they relate to depression where serotonin imbalance affects the 5-HT2A receptor's role in mood regulation. These receptor's interactions with other proteins such as those involved in stress response and signal regulation underline their influence in such disorders highlighting potential therapeutic targets for intervention.